Form 4: Envoy Medical Director Michael Crowe Acquires Stock Options
SEC Form 4 Filing
Director Michael Curtis Crowe acquired stock options for 25,000 shares of Envoy Medical, Inc. on August 8, 2024.
Summary
- Michael Curtis Crowe, a director of Envoy Medical, Inc. (COCH), reported a transaction involving stock options.
- On August 8, 2024, Crowe acquired options to purchase 25,000 shares of Class A Common Stock at an exercise price of $2.40.
- These options vest over a period of 37 months, with 6,250 shares vesting on August 8, 2025, and the remaining 18,750 shares vesting pro rata monthly thereafter.
- Following the transaction, Crowe directly owns options for 25,000 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of stock options by a director can be seen as a sign of confidence, but it's a routine transaction.
Positives
- A director's acquisition of stock options can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into insider transactions, allowing investors to monitor the actions of company directors and officers.
Stakeholder Impact
- The transaction provides shareholders with information about insider activity, which can influence investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 08/08/2024 | Date of transaction: Michael Crowe acquired stock options for 25,000 shares; Exercise price is $2.40 |
| 08/08/2025 | Vesting start date: 6,250 shares vest on this date. |
| 08/08/2034 | Expiration date of the stock options. |
| 08/12/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.